The U.S. Food and Drug Administration has downgraded the classification of full-field digital mammography devices from high risk to medium risk, making it easier for companies to bring the technology to market, the agency announced today.
FDA eases rules on digital mammography devices
Nov 3, 2010
Latest in Breast
Half of false-negative DBT exams are missed cancers
October 5, 2026
EHR data may miss women eligible for lung cancer screening
September 28, 2026
Ikonopedia updates breast reporting platform for BI-RADS v2025
September 17, 2026
UH-WBI use increased during COVID-19 pandemic
September 11, 2026
















